Zhen Bo Su
Director/Board Member at CASI PHARMACEUTICALS, INC.
Profile
Mr. Zhen Bo Su is an Independent Director at CASI Pharmaceuticals, Inc., a Managing Partner at Shenzhen Share Investment LP, a Partner at Guangzhou Redhill Capital Investment Management Co. , Ltd.
and a Partner at Redhill Capital Investment Management Co. Ltd.
He is on the Board of Directors at CASI Pharmaceuticals, Inc. and Shenzhen Share Investment LP.
Mr. Su was previously employed as a Co-Founder by Chongqing TCR CURE Biopharma Technology Co., Ltd, an Executive Director by Genetron Holdings Ltd., an Executive Director by LIGHT VISION CO., LTD., an Executive Director by Meyer FSMP Hong Kong Ltd., an Executive Director by Polyrey Medical Tech (Suzhou) Co., Ltd., and an Executive Director by TCRCcure Biopharma Ltd.
He received his undergraduate degree from Guangdong Medical University, a graduate degree from Sun Yat-Sen University and an MBA from The University of Chicago.
Zhen Bo Su active positions
| Companies | Position | Start |
|---|---|---|
| CASI PHARMACEUTICALS, INC. | Director/Board Member | 2023-03-20 |
Shenzhen Share Investment LP
 Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Director/Board Member | - |
| Redhill Capital Investment Management Co. Ltd. | Corporate Officer/Principal | - |
Former positions of Zhen Bo Su
| Companies | Position | End |
|---|---|---|
| Meyer FSMP Hong Kong Ltd. | Director/Board Member | - |
| LIGHT VISION CO., LTD. | Director/Board Member | - |
Polyrey Medical Tech (Suzhou) Co., Ltd.
 Polyrey Medical Tech (Suzhou) Co., Ltd. Medical SpecialtiesHealth Technology Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China. | Director/Board Member | - |
| GENETRON HOLDINGS LIMITED | Director/Board Member | - |
| TCRCcure Biopharma Ltd. | Director/Board Member | - |
Training of Zhen Bo Su
| The University of Chicago | Masters Business Admin |
| Sun Yat-Sen University | Graduate Degree |
| Guangdong Medical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CASI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Polyrey Medical Tech (Suzhou) Co., Ltd.
Polyrey Medical Tech (Suzhou) Co., Ltd. Medical SpecialtiesHealth Technology Polyrey Medical Tech (Suzhou) Co., Ltd. engages in the development, manufacture, and sale of medical instruments in treating vascular diseases. It focuses on coronary catheterization and outer periphery balloon dilatation catheters. The company was founded by Lie Tang on August 3, 2011 and is headquartered in Suzhou, China. | Health Technology |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
Chongqing TCR CURE Biopharma Technology Co., Ltd
 Chongqing TCR CURE Biopharma Technology Co., Ltd Pharmaceuticals: MajorHealth Technology Chongqing TCR CURE Biopharma Technology Co., Ltd is a company that develops immunotherapy for T cell cancer. The company is based in Chongqing, China. and has subsidiaries in China. The Chinese company was founded in 2016 by Wei-Wu He, Zhen Bo Su, Qi-Jing Li, Pin Wang. Qi-Jing Li has been the CEO since 2016. | Health Technology |
| TCRCcure Biopharma Ltd. | |
| Meyer FSMP Hong Kong Ltd. | |
| LIGHT VISION CO., LTD. | |
| Redhill Capital Investment Management Co. Ltd. | |
Shenzhen Share Investment LP
Shenzhen Share Investment LP Investment ManagersFinance Shenzhen Share Investment LP is an independent venture capital firm founded in 2007 by Bai Wen Tao, Cui Xin Xin, and Huang Fan Zhi. The firm is headquartered in Shenzhen, China. | Finance |
- Stock Market
- Insiders
- Zhen Bo Su
